Volpara Health Technologies Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VPAHF research report →
About the company
Established in 2009 and headquartered in Wellington, New Zealand, Volpara Health Technologies Limited specializes in developing advanced software solutions, primarily for breast imaging analytics. The company's diverse product portfolio aims to enhance and optimize various aspects of cancer screening. Key offerings include Volpara Analytics, which streamlines breast cancer screening operations, and Volpara Live, providing instant, patient-specific feedback on image quality.
- CEO
- Teri Jo Thomas
- IPO
- 2018
- Employees
- 156
- HQ
- Wellington, NZ
Price Chart
- Market Cap
- $188.24M
- P/E
- -32.34
- P/S
- 9.13
- P/B
- 6.03
- EV/EBITDA
- -56.51
- Div Yield
- 0.00%
- Gross Margin
- 76.79%
- Op Margin
- -37.06%
- Net Margin
- -27.99%
- ROE
- -17.60%
- ROIC
- -20.44%
- Revenue
- $32.77M · 35.02%
- Net Income
- $-9,174,389.217 · 39.96%
- EPS
- $-0.04 · 40.13%
- Op Income
- $-10,297,669.194
- FCF YoY
- 53.56%
- 52W High
- $0.89
- 52W Low
- $0.41
- 50D MA
- $0.72
- 200D MA
- $0.60
- Beta
- 1.67
- Avg Volume
- 340
Get TickerSpark's AI analysis on VPAHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our VPAHF coverage
Recent articles, reports, and earnings notes.
No research on VPAHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VPAHF report →Similar companies
Peers in the same neighborhood.